BMJ  2006;332:11-17 (7 January), doi:10.1136/bmj.38677.559005.55 (published 5 December 2005)

Research

Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux

A B Chang, consultant in paediatric respiratory medicine1, T J Lasserson, review group coordinator2, T O Kiljander, consultant in respiratory medicine3, F L Connor, consultant in paediatric gastroenterology4, J T Gaffney, research nurse1, L A Garske, consultant in respiratory medicine5

1 Department of Respiratory Medicine, Royal Children's Hospital, Herston, Brisbane, Qld 4029, Australia, 2 Cochrane Airways Group, St George's Hospital Medical School, London SW17 0RE, 3 Medical Center Mehiläinen, Kauppiaskatu 8, FIN-20100 Turku, Finland, 4 Department of Gastroenterology, Royal Children's Hospital, Herston, Brisbane, 5 Princess Alexandra Hospital, Brisbane, Woolloongabba, Qld 4102, Australia

Correspondence to: A Chang annechang{at}ausdoctors.net

Abstract

Objective To evaluate the efficacy of treatment for gastro-oesophageal reflux disease (GORD) on chronic cough in children and adults without an underlying respiratory disease.

Design Systematic review and meta-analysis.

Data sources Cochrane, Medline, and Embase databases, references from review articles.

Included studies Randomised controlled trials on GORD treatment for cough in children and adults without primary lung disease. Two reviewers independently selected studies and extracted paediatric and adult data on primary (clinical failure) and secondary outcomes.

Results 11 studies were included. Meta-analysis was limited to five studies in adults that compared proton pump inhibitors with placebo. All outcomes favoured proton pump inhibitors: the odds ratio for clinical failure (primary outcome) was 0.24 (95% confidence interval 0.04 to 1.27); number needed to treat (NNT) was 5 (harm 50 to {infty} to benefit 2.5). For secondary outcomes, the standardised mean difference between proton pump inhibitors and placebo was -0.51 (-1.02 to 0.01) for mean cough score at the end of the trial and -0.29 (-0.62 to 0.04) for change in cough score at the end of the trial. Subgroup analysis with generic inverse variance analysis showed a significant mean change in cough (-0.41 SD units, -0.75 to -0.07).

Conclusion Use of a proton pump inhibitor to treat cough associated with GORD has some effect in some adults. The effect, however, is less universal than suggested in consensus guidelines on chronic cough and its magnitude of effect is uncertain.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Role of gastro-oesophageal reflux treatment for chronic cough may be in doubt
BMJ 2006 332: 0. [Full Text] [PDF]

Doing things differently
Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

Confidence intervals for the number needed to treat
Douglas G Altman
BMJ 1998 317: 1309-1312. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Lim, K. G. (2009). Improving Access to Specialty Care for Chronic Cough. Chest 136: 959-961 [Full text]  
  • Field, S. K., Conley, D. P., Thawer, A. M., Leigh, R., Cowie, R. L. (2009). Effect of the Management of Patients With Chronic Cough by Pulmonologists and Certified Respiratory Educators on Quality of Life: A Randomized Trial. Chest 136: 1021-1028 [Abstract] [Full text]  
  • Tsai, T.-L., Chang, S.-Y., Ho, C.-Y., Kou, Y. R. (2009). Role of ATP in the ROS-mediated laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats. J. Appl. Physiol. 106: 1584-1592 [Abstract] [Full text]  
  • Chang, A B, Bilton, D (2008). Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis. Thorax 63: 269-276 [Abstract] [Full text]  
  • McGarvey, L.P.A., Polley, L., MacMahon, J. (2007). Review Series: Chronic cough: Common causes and current guidelines. Chronic Respiratory Disease 4: 215-223 [Abstract]  
  • Chang, A. B., Gibson, P. G., Ardill, J., McGarvey, L. P. A. (2007). Calcitonin gene-related peptide relates to cough sensitivity in children with chronic cough. Eur Respir J 30: 66-72 [Abstract] [Full text]  
  • Vertigan, A.E., Theodoros, D.G., Gibson, P.G., Winkworth, A.L. (2007). REVIEW SERIES: Chronic cough: Behaviour modification therapies for chronic cough. Chronic Respiratory Disease 4: 89-97 [Abstract]  
  • Vertigan, A E, Theodoros, D G, Gibson, P G, Winkworth, A L (2006). Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 61: 1065-1069 [Abstract] [Full text]  
  • Schunemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., Manthous, C. A., Maurer, J. R., McNicholas, W. T., Oxman, A. D., Rubenfeld, G., Turino, G. M., Guyatt, G., on behalf of the ATS Documents Development and Imp, (2006). An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations. Am. J. Respir. Crit. Care Med. 174: 605-614 [Full text]  
  • (2006). Treating GERD-Associated Cough. JWatch General 2006: 7-7 [Full text]  

Rapid Responses:

Read all Rapid Responses

Meta-analysis in chronic cough
Alyn H Morice
bmj.com, 24 Jan 2006 [Full text]
Is treatment for chronic cough associated with gastro-oesophageal reflux evidence based?
Ms. Natasha Choudhury, et al.
bmj.com, 1 Feb 2006 [Full text]
Not all reflux is gastro-oesophageal
Jonathan C Hobson, et al.
bmj.com, 7 Feb 2006 [Full text]
Reflux and cough: a phenomenon that needs clarification
Silvia Salvatore, et al.
bmj.com, 15 Feb 2006 [Full text]
clarification of data
Anne B Chang, et al.
bmj.com, 17 Feb 2006 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ